Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2968155
Title:
FORMES PHARMACEUTIQUES ORALES DE TOFACITINIB A LIBERATION PROLONGEE
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
147264105
WO application number:
IB2014059689
Type:
European patent granted for BE
Status:
Open
Publication number:
2968155
WO publication number:
WO2014147526
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
12/03/2014
Grant date:
03/03/2021
EP publication date:
20/01/2016
WO publication date:
25/09/2014
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
03/03/2021
EP B1 publication date:
03/03/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
12/03/2034
Applicant
1
Name:
Pfizer Inc.
Legal Form:
From:
16/03/2023
Address:
66 Hudson Boulevard East, New York, NY 10001‐2192 , United States (US)
To:
2
Name:
Pfizer Inc.
Legal Form:
From:
03/03/2021
Address:
235 East 42nd Street, New York, NY 10017, United States (US)
To:
16/03/2023
Agent
1
Name:
GEVERS PATENTS
Legal Form:
From:
08/02/2024
Address:
De Kleetlaan 7A, 1831, DIEGEM, Belgium (BE)
To:
2
Name:
GEVERS PATENTS
Legal Form:
From:
13/04/2021
Address:
Holidaystraat 5, 1831, DIEGEM, Belgium (BE)
To:
08/02/2024
Inventor
1
Name:
HERBIG, Scott Max
Legal Form:
Address:
East Lyme, Connecticut 06333, United States (US)
2
Name:
KRISHNASWAMI, Sriram
Legal Form:
Address:
East Lyme, Connecticut 06333, United States (US)
3
Name:
KUSHNER IV, Joseph
Legal Form:
Address:
Bradford, Rhode Island 02808, United States (US)
4
Name:
LAMBA, Manisha
Legal Form:
Address:
Waterford, Connecticut 06385, United States (US)
5
Name:
STOCK, Thomas C.
Legal Form:
Address:
Chester Springs, Pennsylvania 19425, United States (US)